with those of controls and moderate drinkers (36) . Some of this loss of brain mass is likely due to actual loss of neurons and resulting loss of myelin sheath white matter, which normally envelops neuronal extensions. However, a portion of the loss in brain mass is also likely to be due to a reduction in the brain parenchyma, that is, the size of the cells and their processes, during chronic alcohol abuse. Recent studies have indicated that within 1 to 5 month (mo) of recovery from alcoholism, and with sustained abstinence, the size of the brain returns toward normal levels. It is likely that this return involves an increase in neuronal cell size, arborization, and density of the neuronal processes that make up cellular brain mass, as well as increases in the number and size of glial cells (27) . Although it is not clear exactly how alcoholism leads to a reduction in brain weight and volume, it is clear that this does occur during active alcohol abuse, and that some recovery of brain mass does occur during abstinence. More studies are needed to more clearly understand how chronic alcohol leads to a reduction in brain mass and what occurs during recovery of brain mass in abstinence.
Recent studies have begun to focus on the frontal lobes as being particularly sensitive to alcohol-induced changes (49) . Quantitative morphometry suggests that the frontal lobes of the human brain show the greatest loss and account for much of the associated ventricular enlargement. Specific types of brain cells appear to be disrupted. Both gray matter, which is composed largely of neurons, and white matter, which involves neuronal tracks surrounded by myelin sheaths, appear to be decreased. Studies have found that neuronal density in the superior frontal cortex is reduced by 22% in alcoholics compared with nonalcoholic controls, in contrast to other areas of the cortex, which were not different between the groups (37) . Further, the complexity of the basal dendritic arborization of layer III pyramidal cells in both superior frontal and motor cortices was significantly reduced in alcoholics compared with controls. A reduction in dendritic arborization of Purkinje cells in the anterior superior vermis of the cerebellum is also found in alcoholics. Taken together, the data demonstrate a selective neuronal loss, dendritic simplification, and reduction of synaptic complexity in specific brain regions of alcoholics. It remains uncertain how these cellular lesions relate to selective loss of white matter that appears to occur particularly in frontal lobes. One reason these frontal lobe changes are more evident is the greater proportion of white matter to cortical gray matter in the frontal regions. Frontal lobe shrinkage has been reported with or without seizures, with recent studies suggesting that temporal lobe shrinkage occurs particularly in individuals with alcohol withdrawal seizure history (93) . Decreases in the amounts of N-acetyl aspartate in the frontal lobe, a measure of neuron levels, also illustrate frontal lobe degeneration in alcoholics (48) . Alcoholics with more severe brain disorders, such as Wernike's and/or Korsakoff's syndrome, show more significant reduction in white matter and more extensive brain region degeneration, which is consistent with the greater alcohol consumption associated with more severely damaged individuals.
Recent studies have found that, in addition to the global shrinkage of brain regions, certain key neuronal nuclei that have broad functions in brain activity are selectively lost with chronic alcohol abuse. Perhaps the most extensively studied are the cholinergic basal forebrain nuclei that are also lost in Alzheimer's disease. Animal studies and some human studies have suggested that this region is particularly damaged in alcoholic subjects. Arendt (3) found a significant loss of neurons in this region in alcoholic Korsakoff psychosis patients. Additional brain nuclei that appear to be particularly sensitive are the locus coeruleus and raphe nuclei. These two nuclei contain many of the noradrenergic and serotonergic neurons within the brain, respectively. Although these nuclei are small in size, they are particularly important because their neuronal processes project throughout the brain and modulate global aspects of brain activity. Chemical studies have shown abnormally low levels of serotonergic metabolites in the cerebral spinal fluid of alcoholics with Wernike's and/or Korsakoff's syndrome, and more recent morphological studies have found a significant reduction, for example, 50%, in the number of serotonergic neurons from the raphe nuclei of all alcoholic cases studied compared with controls. Thus, the serotonergic system appears to be disrupted in alcoholics, especially in severe alcoholics (8, 33) . Several studies have also reported significant noradrenergic cell loss in the locus coeruleus (2, 5, 60) , although not all studies have found this loss (36) . Recent studies have also indicated that certain neurons that contain the peptide vasopressin may be sensitive to chronic ethanol-induced neurotoxicity in both rats and humans (34, 62) . Damage to hypothalamic vasopressin and other peptide-containing neurons could disrupt a variety of hormone functions as well as daily rhythms that are important for healthy living. Additional studies are needed to determine which specific cell groups within the brain might be particularly damaged. The findings of specific neuronal loss in small, but functionally significant brain areas could result in global changes in attention, mood, and personality that are difficult to quantify but that have a great impact on brain function and overall behavior.
Recent studies have found that long-term ethanol intoxication is not necessary to cause brain damage. Studies have shown that as little as a few days of intoxication can lead to neuronal loss in several brain areas including dentate gyrus, entorhinal, piriform, insular, orbital, and perirhinal cortices and in the olfactory bulb (18) . These structures are involved in frontal cortical neuronal circuits including the limbic and association cortex. These findings are consistent with recent human studies reporting damage to the entorhinal cortex (45) and significant hippocampal shrinkage in alcoholics (35) . Hippocampal damage during chronic ethanol treatment has been correlated with deficits in spatial learning and memory (27) . Thus, cortical and hippocampal damage also occur with chronic ethanol treatment, and relatively short durations of alcohol abuse may cause some form of damage. Additional studies are needed to understand the molecular mechanisms involved in selective neuronal death and the factors that regulate brain regional sensitivity to ethanol neurotoxicity.
New exciting studies have begun to address the effects of gender on brain damage. Interestingly, alcoholic women appear to have an increased sensitivity for brain damage when compared with alcoholic men (42) . This appears to be true for liver disease as well. Although there are more men diagnosed as alcoholic, the numbers of alcoholic women are increasing. The increased susceptibility of women to alcoholic pathology is an area that needs further experimentation.
Alcoholics who do not have Korsakoff's problems do show decreased neuropsychological performance in comparison with peer nonalcoholics on tests of learning, memory, abstracting, problem-solving, visuospatial and perceptual motor functioning, and information processing (78) . Alcoholics not only are less accurate but also take considerably longer to complete tasks. Alcoholics are differentially vulnerable to these deficits. Further, many of the deficits appear to recover to age-appropriate levels of performance over a 4-to 5-year period of abstinence (78) . Although global cerebral atrophy returns to normal levels with extended abstinence, not all cognitive functions return. Some abstinent alcoholics appear to have permanent cognitive impairments, particularly in memory and visual-spatial-motor skills (23) . Other studies support a loss of logical memory and paired association learning tasks in alcoholics that may be long lasting (24) . Cognitive deficits are not the only factors that suggest long-term changes in brain function following chronic ethanol treatment.
Electrophysiological studies using brain electroencephalograms (EEGs) and event-related potentials (ERPs) have suggested that alcoholics have difficulty differentiating relevant and irrelevant, easy and difficult, and familiar and unfamiliar stimuli (80) . These deficits appear to be consistent for alcoholics and may be related to frontal cortical function. Both clinical and experimental studies support a role of frontal cortical involvement in neuropsychological dysfunction in alcoholics, particularly those with Korsakoff's syndrome (77) . Factors affected include emotional abilities, disinhibition, perseverative responding, reduced problem-solving abilities, and poor attention. Prefrontal damage typically is associated with changes in personality and elusive cognitive abnormalities. Recent studies have emphasized the role of the prefrontal cortex on executive cognitive functions (29) . Executive cognitive function is the ability to utilize higher mental abilities such as attention, planning, organization, sequencing, abstract reasoning, and the ability to utilize external and internal feedback to adaptively modulate future behavior (26) . These functions are dysfunctional in alcoholics and those with other diseases showing prefrontal damage (10) , and disruption of these functions has been implicated in the underlying aggression associated with substance abuse (39) . Although these types of changes in brain function are more difficult to assess, they are consistent with the morphological changes found in the frontal cortex and with recent studies on damage to the association cortex in animals.
EXCITOTOXICITY
The mechanisms of ethanol neurotoxicity have only recently been elucidated. There are several reports that N-methyl-D-aspartic acid (NMDA)-glutamate receptors may be involved in tolerance to and dependence on ethanol as well as ethanol-induced brain damage. When MK-801 (dizocilpine), an antagonist to NMDA-glutamate receptors, is coadministered with ethanol, the tolerance to ethanol was eliminated (52, 94) . More recently, Khanna et al. (51) found that inhibition of nitric oxide also inhibited the development of tolerance to ethanol and that NMDA receptors are closely coupled to nitric oxide formation (15) . Thus, NMDA receptors appear to be involved in the development of tolerance to ethanol.
Hyperexcitability of the CNS is a key component of ethanol withdrawal, and a supersensitive glutamate-NMDA response appears to be involved, although a reduction in GABA-mediated inhibition may contribute as well (20) . One of the earliest findings suggesting glutamate involvement was the finding that [ 3 H]glutamate binding is increased in the human hippocampus of alcoholics (67) . Although the subtype of the glutamate receptor involved is not clear, this is consistent with increased glutamate receptor density and sensitivity. NMDA-glutamate receptors have recently been discovered to have a unique property, in that excessive stimulation of these receptors triggers a process in neurons that leads to neuronal death. This appears to play a key role in neurodegenerative diseases in general as well as stroke, brain trauma, and other types of brain damage (20) .
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Basic studies on alcohol have contributed significantly to the understanding of this process. Several studies in isolated neuronal cells have indicated that a few days of chronic ethanol treatment lead to supersensitive NMDA-stimulated calcium flux (1, 46) , as well as NMDA-stimulated excitotoxicity (19, 21, 47) and NMDA-stimulated nitric oxide formation (17) . Nitric oxide has been implicated in neuronal toxicity due to the formation of highly oxidative metabolites (19 (91) . Changes in some NMDA ligand-binding sites and not others may be involved in subunit composition changes and not an increased density of channels. Trevisan et al. (95) found that 12-week (w) administration of ethanol liquid diet to rats increased the levels of NMDAR1 immunoreactivity in the hippocampus, but not the cortex, striatum, or nucleus accumbens, whereas other studies of levels of NMDAR1 mRNA have indicated that chronic ethanol does not change NMDAR1 mRNA but increases NMDAR2A and NMDAR2B mRNA levels in the hippocampus and cortex (25) . It is important to note that some studies have not found increases in MK-801 binding following chronic ethanol treatment of mice (13) or rats (86) . These differences could be due to different ethanol treatment protocols or the responses of different strains of animals. Long-term treatment of rats with ethanol (12 w) was found to be required to increase NMDAR1 immunoreactivity in the ventral tegmental area, whereas 1 and 6 w of chronic 5% ethanol liquid diet were not sufficient (76) . Although the exact molecular processes require additional experimentation, a number of studies support the hypothesis that chronic ethanol results in supersensitive NMDA receptors and that this could be a significant factor in ethanol-induced brain damage.
The mechanism of the neurodegeneration in alcoholic Wernicke's syndrome also appears to involve excitotoxicity from glutamate in the neural destructive process similar to the less severe alcoholic brain damage (55) . In animal studies, extracellular concentrations of glutamate in the brain increase several-fold during seizures in thiamine-deficient animals (55) . Furthermore, MK-801, an NMDA antagonist, reduces experimental neurobiological symptoms and the severity of neural lesioning in thiamine-deficient rats (54). It is not known whether administration of ethanol in thiamine deficiency would enhance the degree of neurodegeneration seen in experimental Wernicke's encephalopathy (i.e., thiamine deficient). A complicating factor of Wernicke's encephalopathy is Korsakoff's amnestic syndrome (98) . In this latter syndrome, there is a major loss of memory. The memory dysfunction correlates best with the presence of lesions in the thalamus (98) . It must be recognized that this latter syndrome can occur in the absence of ethanol, although it is extremely rare. However, in susceptible individuals, chronic ethanol clearly facilitates the course of this disease. In any case, there is strong evidence that ethanol withdrawal hyperexcitability is related, at least in part, to NMDA supersensitivity and that this supersensitivity could underlie ethanol-induced brain damage. In summary, chronic ethanol appears to cause NMDA receptor supersensitivity in a variety of systems. NMDA supersensitivity is probably involved in ethanol tolerance, dependence, withdrawal, and neurotoxicity.
OXIDATIVE STRESS
Another likely mechanism of ethanol-induced brain damage involves increased oxidative stress of neurons. Cells use oxygen for energy metabolism, but they normally have protective mechanisms against oxidative damage. Studies examining the effects of both acute and chronic ethanol administration upon cellular oxidation have primarily focused on either ethanol's effects upon intracellular antioxidant mechanisms, such as α-tocopherol, ascorbate, glutathione, catalase, and superoxide dismutase (SOD) activity (58, 70, 73, 85) , or potential sources of oxidative radicals, such as CYP2E1, an ethanol-inducible form of cytochrome-P450 and a potent generator of oxidative radicals (69, 70) . Chronic ethanol-induced increases in CYP2E1 and other oxidases have been related to increased lipid peroxidation and reactive oxygen radicals in the brain (70) . However, levels of antioxidant enzymes, such as catalase and superoxide dismutase, appear to increase as a compensatory mechanism to ethanol-induced oxidant enzyme levels (70) . The brain is particularly susceptible to lipid peroxidation, since it consumes a large amount of oxygen and is rich in polyunsaturated fatty acids, which are especially prone to reactive oxygen injury. It has been demonstrated that a single dose of ethanol results in both the elevation of lipid hydroperoxide levels and decreases in glutathione levels in rat brain homogenates (74, 75, 96, 97) . However, it is not clear how this increased oxidation translates to increased brain damage, if it does at all. Although most studies have focused on the whole brain, a recent study of ethanol-induced depression of glutathione and glutamine synthetase levels, two indices in increased oxidative radical formation, found changes only in the striatum but not in the cerebral cortex or cerebellum (11) . Oxidative stress has been implicated in a variety of conditions, particularly aging, Alzheimer's disease, Parkinsonism, stroke, and other neurodegenerative diseases. Much more research is needed to completely understand the nature of how oxidation damages neurons and how other brain cells respond to increased oxidative stress. Ethanol-induced neurodegeneration may be related to an in-F. T. CREWS duction of oxidative enzymes, and alcohol research provides an opportunity to clearly address this aspect of neurodegeneration that could impact a broad range of mental diseases.
NEUROTROPHIC FACTORS
Neurotrophins are small protein growth factors that have profound influences upon the development, survival, regulation of function, and plasticity of neurons. The neurotrophin family includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5. Although the neurotrophins share 50 to 55% homology of the amino acid sequence, the different neurotrophins promote survival of distinct sets of neurons through distinct receptors. For example, sympathetic neurons respond to NGF and NT-3 but not to BDNF (63) , whereas dopamine neurons respond to BDNF and NT-3 but not to NGF (44) . All members of the neurotrophin family bind to a low affinity receptor, p75, and each member binds to a high affinity trk tyrosine kinase receptor. Signal transduction involves both the tyrosine kinase signals and the internalization and transport of the neurotrophin-receptor complex. Since neurotrophins contribute to the survival of neurons and their resistance to insults, ethanol-induced changes in neurotrophin levels and/or signaling could contribute to ethanol-induced neurotoxicity.
Much of the research on chronic ethanol and trophic factors has focused on the hippocampus and the neuronal loss and atrophy of cholinergic and GABAergic neurons in the septohippocampal pathway that are known to occur with chronic ethanol treatment (3, 72, (99) (100) (101) (102) . These neurons are known to require neurotrophins for normal function and survival. Arendt et al. (5) found that 28 w of ethanol liquid diet (20% v/v) decreased choline acetyltransferase and other cholinergic-specific neuronal markers by about 60 to 80%, but the reduction in the number of neurons expressing the nerve growth factor receptor component p75 was only 20 to 30% (5) . In contrast to reduced neurotrophin receptors, NGF mRNA was significantly increased throughout the brain, with pronounced increases in the hippocampus where chronic ethanol treatment increased NGF mRNA approximately twofold (4) . Increased NGF expression is known to occur as a result of brain injury (28, 53) . The increased NGF mRNA following chronic ethanol treatment may be due to the neuronal damage caused by ethanol. Arendt et al. (4) found increased NGF mRNA 4 w after removal from the ethanol diet, consistent with a long-term change in NGF expression in response to ethanol neurotoxicity. Although the increased NGF mRNA was associated with dendritic remodeling, the expression of choline acetyltransferase remained decreased, suggesting that the increased NGF signal is not sufficient or is blunted such that, in chronic ethanol-damaged rat brain, the increased NGF cannot completely restore choline acetyltransferase expression (4). These studies suggest that chronic ethanol-induced damage induces NGF expression. Baek et al. (6) reported that a regimen of 28 w of chronic ethanol diet that causes septohippocampal damage does not change immunoreactive NGF levels or NGF mRNA when animals are sacrificed just after the ethanol has cleared from the blood. Interestingly, a third study has found that chronic ethanol treatment of rats leads to elevated NGF content in the hippocampus after 2 w and 1 mo but not after 3 mo of chronic ethanol administration (71) . Nine months of ethanol liquid diet treatment decreased sciatic nerve NGF by 54%, but this treatment had no effect on the NGF content of the iris, superior cervical ganglion, trigeminal ganglion, or submandibular ganglion (38) . Taken together, these studies suggest that NGF levels increase under certain conditions in response to tissue injury, but not sufficiently to correct chronic ethanol-induced damage to the septohippocampal pathways.
Although NGF levels were either unchanged or increased following chronic ethanol treatment, chronic ethanol treatment decreased both the neuronal survival (-25%) and the neurite-outgrowth (-50%) neurotrophic activities of hippocampal extracts relative to controls assessed using neuronal culture bioassays (103) . At least 21 w of chronic ethanol treatment were required to reduce neurotrophic activity within the hippocampus. After 28 w of chronic ethanol treatment, both, neurotrophic activity levels and morphological changes due to ethanol, were found in the septal and hippocampal areas (100,102), suggesting that there may be a relationship between damage and loss of trophic activity. Measurement of mRNA for NT-3, basic fibroblast growth factor (bFGF), and BDNF indicated that only BDNF appeared to be reduced by 21 to 28 w of chronic ethanol treatment (7, 61) . The loss of BDNF during chronic ethanol treatment likely plays a role in chronic ethanol-induced damage to the septohippocampal pathway (7, 61) .
Growth factors and NMDA receptors are linked in a number of ways. Growth factors have been found to reduce neuronal sensitivity to NMDA excitotoxicity and oxidative radical formation (66) . In contrast, sublethal NMDA stimulation has been shown to have a protective effect on the survival of cerebellar granule cells by inducing BDNF (9, 65) . BDNF through a tyrosine kinase mechanism can actually enhance NMDA receptor responses (59). Ethanol-induced blockade of NMDA receptors during chronic administration could contribute to decreased BDNF expression and increased neurotoxicity (9) . Loss of BDNF would specifically alter certain neuronal cell types that are particularly sensitive to BDNF. BDNF has been shown to increase the survival of both dopamine neurons (43, 92) and serotonin neurons (64) . An example of how protection of excitotoxicity by growth factors might interact in chronic ethanol-induced brain damage is shown in Fig. 1 . In this experiment, dopamine-containing neurons are distinguished by tyrosine hydroxylase immunoreactivity along with brain regional dissection of dopamine (DA)-but not norepinephrine (NE)-containing neurons. Treatment of neurons with NMDA for a short period in controls actually increased the density of these neurons, consistent with sublethal NMDA stimulation's actually having a trophic effect (14) . However, pretreatment with ethanol for 2 d followed by removal of the ethanol, simulating ethanol withdrawal, resulted in an NMDA neurotoxic response (22) similar to other studies showing that chronic ethanol can cause supersensitive NMDA excitotoxicity (16, 21) . BDNF addition to the culture protected against ethanol-induced sensitization to NMDA excitotoxicity in dopamine neurons (22) . Chronic ethanol has been found to reduce brain levels of BDNF (7, 61) . Thus, a mechanism of ethanol neurotoxicity includes reductions in BDNF production sensitizing neurons to insults.
Receptors for the growth factors are also modified by chronic ethanol treatment. Studies have found that chronic ethanol can decrease levels of p75 neurotrophin receptors (5, 90) . In contrast, chronic ethanol treatment of rats for 28 w has been found to increase trk B-like protein expression, suggesting an upregulation of BDNF receptor response elements as a compensatory reaction to the decrease in BDNF levels (7) . Other studies have found ethanol disruption of neuronal calcium that can be reversed by NGF (104) . Ethanol has also been reported to disrupt tyrosine kinase signaling of insulin growth factor receptors (105) . Thus, the interaction of ethanol with growth factors could play a key role in ethanol neurotoxicity. Studies of growth factor action and their role in ethanol-induced CNS Drug Reviews, Vol. 5, No. 4, 1999 386 F. T. CREWS (22) . Dopamine neurons were counted as tyrosine hydroxylase-immunopositive cells 24 h following treatment. Note that dopamine neurons treated with ethanol are sensitized to NMDA toxicity, whereas simultaneous treatment with BDNF prevents ethanol-induced NMDA excitotoxic sensitization. Dopamine neurons were prepared as neuronal cultures from embryos of timed pregnant Sprague-Dawley rats on Day 14 and dissected from the surrounding membranes. The mesencephalon containing tyrosine hydroxylase neurons of the A9-A10 groups was dissected and cultured. Dopamine neurons were identified using tyrosine hydroxylase immunohistochemistry. On Day 0 and on Day 3, BDNF (50 ng/ml) was added. At 1 day in vitro (DIV), ethanol (100 mM) was added for 48 h. At 3 DIV, the medium was removed, and the cultures were treated with either NMDA or control medium. NMDA treatment was for 25 min (60 µM) followed by 24 h of control medium to allow the delayed neuronal death of NMDA excitotoxicity to develop. Mean cells with positive immunoreactivity (IR) were counted in 20 separate grids that are equivalent to 2.5 mm 2 . Shown is the mean ± S.E.M. (n = 9). *P < 0.05; **P < 0.01; ***P < 0.001 vs. control.
brain damage represent an exciting new area of discovery with the tremendous potential to provide a variety of new approaches to treating neurodegeneration.
APOPTOSIS
Apoptosis is a physiological form of cell death with characteristic morphological and biochemical features that include nuclear pyknosis, DNA fragmentation, and dependence upon new protein synthesis. A cascade leading to apoptotic cell death includes induction of p53 protein; recruitment of other transcription factor proteins such as bax, bcl, and bad; and activation of a series of caspase proteases and tyrosine kinases. Few of these have been studied in the intact brain. Although some reports have suggested a role in excitotoxic cell death, most studies have found excitotoxicity to be primarily necrotic. A few studies have reported that adrenalectomy-induced loss of dentate granule cells (88) or kainate-induced cell death (87) is associated with induction of p53, suggesting that apoptosis may occur in the intact adult brain. However, few other studies have extended these findings, and most studies have been done in cell culture with neonatal neurons. Recent studies have suggested that apoptosis is common during development, but that necrosis predominates in the adult brain (81) . Few ethanol studies have been done. In culture, ethanol has been found to inhibit NMDA inhibition of apoptosis in cerebellar granule cell cultures (40) . In astroglial cultures, ethanol-induced death was found to be due to necrotic but not apoptotic mechanisms (41) . Thus, few studies support a major role of apoptotic death in ethanol-induced brain damage in adults, although important actions may occur as part of ethanol's teratogenic actions.
CELL ADHESION MOLECULES
Cell adhesion molecules clearly play a role in neuronal structure and function. Chronic treatment with NMDA antagonists results in neuronal damage and increased NMDA receptor clustering (84) . Since ethanol is an NMDA antagonist, it is possible that this results in structural changes on cell adhesion proteins or cytoskeletal elements. Ramanathan et al. (83) have found that ethanol potently and completely inhibits L1-mediated cell adhesion in transfected cells but has no effect on other adhesion molecules such as NCAM 140. Studies in chick development have implicated ethanol's teratogenic effects due to a disruption of cell adhesion molecule synthesis and function (50) . This is a new and exciting area; however, there are not sufficient data relating adhesion proteins to ethanol's neurotoxic actions to allow conclusions at this time.
BRAIN DAMAGE AND ALCOHOLISM: IMPLICATIONS FOR THE PROGRESSION TO ALCOHOL DEPENDENCE
Alcoholism is a progressive disease that starts with experimentation and progresses to addiction, usually over the course of several years. Addiction involves the loss of control over the ability to abstain from the drug and perseverative preoccupation with obtaining CNS Drug Reviews, Vol. 5, No. 4, 1999 388 F. T. CREWS and using the drug. Although earlier studies focused on alcohol-induced changes in cognition, more recent studies have begun to focus on the frontal cortex and the role of this brain region in behavior. Studies have begun to investigate executive cognitive function (ECF) as an important function of the prefrontal cortex. As mentioned above, a variety of evidence has focused attention on the prefrontal cortex as an area of the brain that is particularly sensitive to alcohol-induced brain damage. At the same time, scientists have developed means to investigate the role of ECF in behavior. ECF/prefrontal cortical characteristics are associated with decreased regulation of human social behavior, including disinhibition syndrome characterized by impulsivity, socially inappropriate behavior, and aggression (30) . Neuroimaging studies have indicated that hypofunction of the frontal lobes is associated with violence (82) . Experimental subjects with poor prefrontal functioning appear unable to inhibit impulsive behavior (56) , particularly violence (57). Taken together, these studies suggest that some of the greatest sociopathic problems of alcoholism, for example, violence and loss of control over the drug, may be directly related to the neurotoxic effects of ethanol on prefrontal cortical function. Animal studies have shown that chronic exposure to alcohol and repeated withdrawal episodes do increase self-administration of ethanol if particularly high blood levels are reached (89) . The progression from experimentation with alcohol to alcohol addiction generally occurs over an extended period of many years with increased consumption of alcohol, increased neurotoxicity, increased distortions of thinking, and preoccupation with the drug (Fig. 2) . Fig. 2 . Spiral of distress depicting the proposed role of alcohol-induced neurochemical changes in the progression from experimentation to alcohol dependence. Experimentation, particularly binge drinking, involves consumption of large amounts of alcohol, inducing genes prior to and during withdrawal. This leads to alterations in neurophysiological processes including increased tolerance and craving that trigger further consumption. Repeated intoxication and withdrawal are very stressful and isolate the individual, triggering further consumption to alleviate stress. Both animal and human studies indicate that chronic ethanol consumption can lead to a reduced number of neurons and/or loss of synaptic markers and turnover indices in cholinergic, adrenergic, serotonergic, and dopaminergic neurons (3). Chronic ethanol treatment also reduces neurotrophic activity, particularly brain-derived neurotrophic factor (BDNF) expression, and causes cortical damage. The selective neuronal loss and more global cortical damage seen in long-term alcoholics may contribute to distortions of thinking, denial of alcohol dependence, and preoccupation with and perseveration of alcohol-seeking behavior with the loss of executive priority-setting functions driving the progression to addiction. DA, dopamine; 5HT, 5-hydroxytryptamine.
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Future studies will be needed to directly determine the relationship of prefrontal cortical function with alcohol-induced brain damage and addiction.
SUMMARY
Alcohol can be neurotoxic. Recent studies have indicated that the prefrontal cortex is particularly sensitive to the neurotoxic actions of alcohol, as are specific groups of neurons that project throughout the brain including the frontal cortex, biogenic amine, and peptidergic neurons. Alcohol-induced brain damage is a significant problem that leads to permanent changes in brain function, although abstinence does allow partial recovery of function. The relationship between alcohol-induced brain damage and the development of alcohol dependence requires additional experimentation, but it presents the possibility that treatments for neurodegeneration and improved cognitive performance could contribute to improved recovery from alcohol dependence.
